Ameriprise Financial Inc 10x Genomics, Inc. Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

A detailed history of Ameriprise Financial Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 60,561 shares of TXG stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,561

Previous 466,354 87.01%

Holding current value

$1.42 Million

Previous $17.5 Million 93.28%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$19.45 - $37.37 $7.89 Million - $15.2 Million	-405,793 Reduced 87.01%	60,561 $1.18 Million
Q1 2024 May 15, 2024	SELL	$36.08 - $54.3 $1.77 Million - $2.66 Million	-48,987 Reduced 9.51%	466,354 $17.5 Million
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $17.2 Million - $28.8 Million	500,802 Added 3444.54%	515,341 $28.8 Million
Q3 2023 Nov 14, 2023	SELL	$40.86 - $62.98 $647,426 - $997,918	-15,845 Reduced 52.15%	14,539 $599,000
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $1.16 Million - $1.34 Million	-22,736 Reduced 42.8%	30,384 $1.7 Million
Q1 2023 May 15, 2023	SELL	$35.33 - $55.79 $201,522 - $318,226	-5,704 Reduced 9.7%	53,120 $2.96 Million
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $147,790 - $250,154	6,057 Added 11.48%	58,824 $2.14 Million
Q3 2022 Nov 14, 2022	SELL	$28.48 - $52.59 $135,194 - $249,644	-4,747 Reduced 8.25%	52,767 $1.5 Million
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $58.3 Million - $130 Million	-1,578,382 Reduced 96.48%	57,514 $2.6 Million
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $2.26 Million - $5.92 Million	40,627 Added 2.55%	1,635,896 $124 Million
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $70.3 Million - $95.1 Million	520,671 Added 48.45%	1,595,269 $238 Million
Q3 2021 Nov 15, 2021	SELL	$145.58 - $192.14 $37.1 Million - $49 Million	-255,124 Reduced 19.19%	1,074,598 $156 Million
Q2 2021 Aug 16, 2021	SELL	$134.22 - $202.37 $10.7 Million - $16.1 Million	-79,485 Reduced 5.64%	1,329,722 $260 Million
Q1 2021 May 17, 2021	BUY	$140.25 - $196.86 $5.27 Million - $7.4 Million	37,573 Added 2.74%	1,409,207 $255 Million
Q4 2020 Feb 12, 2021	BUY	$126.47 - $163.7 $76.7 Million - $99.3 Million	606,538 Added 79.28%	1,371,634 $194 Million
Q3 2020 Nov 16, 2020	BUY	$87.44 - $125.0 $19.6 Million - $28 Million	224,219 Added 41.45%	765,096 $95.4 Million
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $20.3 Million - $31.1 Million	347,974 Added 180.39%	540,877 $48.3 Million
Q1 2020 May 15, 2020	BUY	$51.57 - $106.62 $9.08 Million - $18.8 Million	176,093 Added 1047.55%	192,903 $12 Million
Q4 2019 Feb 14, 2020	BUY	$46.07 - $79.54 $280,382 - $484,080	6,086 Added 56.75%	16,810 $1.28 Million
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $536,092 - $664,888	10,724 New	10,724 $540,000

Others Institutions Holding TXG

# of Institutions

284

Shares Held

96.2M

Call Options Held

162K

Put Options Held

107K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $2.23B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc 10x Genomics, Inc. Transaction History